Kodiak Sciences (KOD) Current Assets (2017 - 2026)
Kodiak Sciences' (KOD) quarterly Current Assets came in at $175.3 million in Q1 2026, up 22.83% YoY from $142.7 million in Q1 2025, and down 18.41% on a QoQ basis from $214.8 million in Q4 2025.
Kodiak Sciences (KOD) Current Assets (2017 - 2026) Analysis & Trends
Kodiak Sciences (KOD) has 10 years of Current Assets data on file, last reported at $175.3 million in Q1 2026.
- Quarterly Current Assets rose 22.83% year-over-year to $175.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $175.3 million (up 22.83% YoY) and the FY2025 annual result came in at $214.8 million, up 24.94% from the prior year.
- Current Assets eased to $175.3 million in Q1 2026, from $214.8 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $682.2 million in Q1 2022 to a low of $75.7 million in Q3 2025.
- A 5-year average of $314.3 million and a median of $251.5 million in 2024 frame the typical range for Current Assets.
- The widest YoY moves for Current Assets: up 24.94% in 2025, down 62.6% in 2025.
- Tracing KOD's Current Assets over 5 years: stood at $486.0 million in 2022, then tumbled by 40.47% to $289.3 million in 2023, then sank by 40.57% to $171.9 million in 2024, then grew by 24.94% to $214.8 million in 2025, then retreated by 18.41% to $175.3 million in 2026.
- The last three Current Assets figures came in at $175.3 million (Q1 2026), $214.8 million (Q4 2025), and $75.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Kodiak Sciences | 2.60 Bn | 2.60 Bn | - | 131.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 131.36 Mn |
| Mar 31, 2026 | 175.26 Mn |
| Dec 31, 2025 | 214.82 Mn |
| Sep 30, 2025 | 75.73 Mn |
| Jun 30, 2025 | 107.92 Mn |
| Mar 31, 2025 | 142.69 Mn |
| Dec 31, 2024 | 171.94 Mn |
| Sep 30, 2024 | 202.49 Mn |
| Jun 30, 2024 | 224.63 Mn |
| Mar 31, 2024 | 251.51 Mn |
| Dec 31, 2023 | 289.31 Mn |
| Sep 30, 2023 | 350.93 Mn |
| Jun 30, 2023 | 386.96 Mn |
| Mar 31, 2023 | 431.12 Mn |
| Dec 31, 2022 | 486.01 Mn |
| Sep 30, 2022 | 544.66 Mn |
| Jun 30, 2022 | 604.37 Mn |
| Mar 31, 2022 | 682.19 Mn |
| Dec 31, 2021 | 734.81 Mn |
| Sep 30, 2021 | 805.51 Mn |